Contract

P0488 - Qualified Person (QP) Service

  • Stockport NHS Foundation Trust

F03: Contract award notice

Notice identifier: 2022/S 000-036259

Procurement identifier (OCID): ocds-h6vhtk-036986

Published 21 December 2022, 4:15pm



Section one: Contracting authority

one.1) Name and addresses

Stockport NHS Foundation Trust

Stepping Hill Hospital, Aspen House

Stockport

SK2 7JE

Contact

Mr Jordan Barry

Email

jordan.barry@stockport.nhs.uk

Telephone

+44 1614195146

Country

United Kingdom

Region code

UKD3 - Greater Manchester

Internet address(es)

Main address

http://www.stockport.nhs.uk

Buyer's address

http://www.stockport.nhs.uk

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

P0488 - Qualified Person (QP) Service

Reference number

DN633365

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

P0488 - Qualified Person (QP) Service

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £192,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKD3 - Greater Manchester

two.2.4) Description of the procurement

Stockport pharmaceuticals part of Stockport NHS Foundation Trust are looking to appoint a

suitable Qualified Person (QP) on a contract basis to work alongside its existing in-house QA

team to support a very active and rapidly growing portfolio of Investigational Medicinal

Product (IMP) manufacturing projects and license applications.

Stockport Pharmaceuticals are a pharmaceutical manufacturing facility based within

Stockport NHS Foundation Trust at Stepping Hill Hospital. The manufacturing facility holds

an MS, MIA and MIA (IMP) License. Stockport Pharmaceuticals manufacture a wide range of

Sterile, Non-Sterile and Aseptically prepared products. Stockport Pharmaceuticals

manufacture IMP for both internally sponsored Clinical Trials and under contract for

academic and commercial clients.

All Stockport Pharmaceutical activities are supported by a very mature Quality Assurance

System compliant with all applicable regulations and frequently inspected by MHRA, and

others.

two.2.5) Award criteria

Quality criterion - Name: Quality / Weighting: 50

Quality criterion - Name: Social value / Weighting: 10

Cost criterion - Name: Whole life costs / Weighting: 40

two.2.11) Information about options

Options: Yes

Description of options

12 month extension available

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2022/S 000-026213


Section five. Award of contract

Contract No

P0488

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

16 November 2022

five.2.2) Information about tenders

Number of tenders received: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Prime QP Services Ltd

26 Willoughby Drive

Merseyside

WA10 3AY

Country

United Kingdom

NUTS code
  • UKD3 - Greater Manchester
The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £192,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Stockport NHS Foundation Trust

Stockport

Country

United Kingdom